Screener
Maravai LifeSciences Holdings, Inc. MRVI Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001823239-26-000059
FAQ
- What is Maravai LifeSciences Holdings, Inc.'s long-term debt?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported long-term debt of $145.98M in Q2 2026.
- How has Maravai LifeSciences Holdings, Inc.'s long-term debt changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s long-term debt decreased by 49.4% year-over-year, from $288.44M to $145.98M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s long-term debt?
- Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s long-term debt has grown at a -11.5% compound annual growth rate (CAGR), from $528.61M to $286.33M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.
Ask your AI about Maravai LifeSciences Holdings, Inc.'s long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude